Cytokinetics: A Heavily Mispriced Cardiovascular Platform

While Cytokinetics ( CYTK ) investors go through the ups and downs surrounding the aficamten PDUFA event , let's not forget that aficamten is only a small part of the company - the forward flank, if you will. Behind itDubai-based investor focused on building a resilient, income-generating portfolio with a long-term growth mindset. My approach is primarily long-only, blending dividend-paying equities, REITs, and other income strategies with selective growth opportunities. I believe in disciplined, fundamenta ...